The inhalant increasing risk of transmission in public transportation, is buses. Biosmart and safe bus apply the principle that the bus compartment which is a biological environment must be in a balanced state according to the disease triangle concept that is influenced by the host, in this case is the passenger, the agent causing the infection is a virus and the environment is the room in the bus cabin. The aim of the present study is to analyze the differences in IgA and IL-6 levels of Biosmart and safe bus passengers and regular bus passengers. This research is a non-blinded randomized control trial with pre-posttest design. Seventy passengers were randomly separated into two groups. Control group (n = 35) uses regular bus, and intervention group uses Biosmart and safe bus (n = 35). Nasal wash was taken by ENT specialists, and the levels of Sinonasal IgA and IL-6 were interpreted by ELISA. The data were analyzed by using Mann Whitney, Wilcoxon, Independent t-test and Paired t-test. The results is sinonasal IgA level got significant increase in all groups, respectively on pretest-posttest of intervention group 17,89 ± 30,19 (p = 0,021), control group 30,18 ± 76,09 (p = 0,014) while the delta IgA level on control group and intervention group resulted in no significant difference (p = 0,182). The IL-6 level also increased in all groups with significant difference (p = 0.000), the delta resulted in significant difference (p = 0,013) with intervention group 13,38 ± 0,96 and control group 13,90 ± 1,27. Interleukin-6 sinonasal levels of Regular Bus and Biosmart and Safe Bus passengers show difference with higher